New insights on depression in multiple sclerosis – a literature review

Nowadays, the success of multiple sclerosis therapy does not only mean the absence of relapses or the existence of a stationary clinical status under disease-modifying therapy, but the maintenance of a high quality of life index. Thus, in recent years, the attention of neurologists has focused on th...

Full description

Bibliographic Details
Main Authors: Thomas Gabriel Schreiner, Bogdan Emilian Ignat
Format: Article
Language:English
Published: Amaltea Medical Publishing House 2020-12-01
Series:Romanian Journal of Neurology
Subjects:
Online Access:https://rjn.com.ro/articles/2020.4/RJN_2020_4_Art-04.pdf
id doaj-5348ccf86215477fa6efac89f725ed30
record_format Article
spelling doaj-5348ccf86215477fa6efac89f725ed302021-08-13T10:32:52ZengAmaltea Medical Publishing HouseRomanian Journal of Neurology1843-81482069-60942020-12-0119423724310.37897/RJN.2020.4.4New insights on depression in multiple sclerosis – a literature reviewThomas Gabriel Schreiner0Bogdan Emilian Ignat1Neurology Department, Clinical Rehabilitation Hospital, Iasi, Romania; “Gr. T. Popa” University of Medicine and Pharmacy, Iasi, Romania; “Carol Davila” University of Medicine and Pharmacy, Bucharest, RomaniaNeurology Department, Clinical Rehabilitation Hospital, Iasi, Romania; “Gr. T. Popa” University of Medicine and Pharmacy, Iasi, RomaniaNowadays, the success of multiple sclerosis therapy does not only mean the absence of relapses or the existence of a stationary clinical status under disease-modifying therapy, but the maintenance of a high quality of life index. Thus, in recent years, the attention of neurologists has focused on the relationship between depression and MS, depression being the most important factor influencing the MS patient’s quality of life. In this regard, the article aims to present a selection of the most important scientific data published during the last 5 years on this topic. Structured in two parts, the initial issue discussed is the etiopathogenesis of depression in MS, with focus on the presentation of theories on the causes of depressive symptoms in demyelinating disease, as well as the intricate relationship between the two clinical entities. Subsequently, the article focuses on capturing the latest developments in currently available pharmacological and non-pharmacological therapeutic means and future prospects for treatment.https://rjn.com.ro/articles/2020.4/RJN_2020_4_Art-04.pdfmultiple sclerosisdepressionethiopathogenytreatment
collection DOAJ
language English
format Article
sources DOAJ
author Thomas Gabriel Schreiner
Bogdan Emilian Ignat
spellingShingle Thomas Gabriel Schreiner
Bogdan Emilian Ignat
New insights on depression in multiple sclerosis – a literature review
Romanian Journal of Neurology
multiple sclerosis
depression
ethiopathogeny
treatment
author_facet Thomas Gabriel Schreiner
Bogdan Emilian Ignat
author_sort Thomas Gabriel Schreiner
title New insights on depression in multiple sclerosis – a literature review
title_short New insights on depression in multiple sclerosis – a literature review
title_full New insights on depression in multiple sclerosis – a literature review
title_fullStr New insights on depression in multiple sclerosis – a literature review
title_full_unstemmed New insights on depression in multiple sclerosis – a literature review
title_sort new insights on depression in multiple sclerosis – a literature review
publisher Amaltea Medical Publishing House
series Romanian Journal of Neurology
issn 1843-8148
2069-6094
publishDate 2020-12-01
description Nowadays, the success of multiple sclerosis therapy does not only mean the absence of relapses or the existence of a stationary clinical status under disease-modifying therapy, but the maintenance of a high quality of life index. Thus, in recent years, the attention of neurologists has focused on the relationship between depression and MS, depression being the most important factor influencing the MS patient’s quality of life. In this regard, the article aims to present a selection of the most important scientific data published during the last 5 years on this topic. Structured in two parts, the initial issue discussed is the etiopathogenesis of depression in MS, with focus on the presentation of theories on the causes of depressive symptoms in demyelinating disease, as well as the intricate relationship between the two clinical entities. Subsequently, the article focuses on capturing the latest developments in currently available pharmacological and non-pharmacological therapeutic means and future prospects for treatment.
topic multiple sclerosis
depression
ethiopathogeny
treatment
url https://rjn.com.ro/articles/2020.4/RJN_2020_4_Art-04.pdf
work_keys_str_mv AT thomasgabrielschreiner newinsightsondepressioninmultiplesclerosisaliteraturereview
AT bogdanemilianignat newinsightsondepressioninmultiplesclerosisaliteraturereview
_version_ 1721208420900536320